Mauro Picardo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 152 publications

Artificial Intelligence-Based Assessment With Line-Field Confocal Optical Coherence Tomography (LC-OCT) During Topical Ruxolitinib Therapy for Vitiligo.

Artificial Intelligence-Based Assessment With Line-Field Confocal Optical Coherence Tomography (LC-OCT) During Topical Ruxolitinib Therapy for Vitiligo.

Journal: International journal of dermatology

Published: July 02, 2026

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

Journal: The British journal of dermatology

Published: May 16, 2026

Treatment of Vulvar Lichen Sclerosus With Topical Ruxolitinib: A Single-Center Study.

Treatment of Vulvar Lichen Sclerosus With Topical Ruxolitinib: A Single-Center Study.

Journal: The Journal of dermatology

Published: April 22, 2026

Healthcare Providers' Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe.

Healthcare Providers' Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe.

Journal: The British journal of dermatology

Published: February 25, 2026

Longitudinal Dermoscopic and LC-OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study.

Longitudinal Dermoscopic and LC-OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study.

Journal: International journal of dermatology

Published: January 30, 2026

Metabolic approach to counteract skin ageing.

Metabolic approach to counteract skin ageing.

Journal: The British journal of dermatology

Published: January 13, 2026

Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey.

Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey.

Journal: Dermatology and therapy

Published: December 23, 2025

Vitiligo.

Vitiligo.

Journal: Nature reviews. Disease primers

Published: November 05, 2025

Early Intervention with Calcineurin Inhibitors in Paediatric Segmental Vitiligo: A Retrospective Case Series.

Early Intervention with Calcineurin Inhibitors in Paediatric Segmental Vitiligo: A Retrospective Case Series.

Journal: Experimental dermatology

Published: October 29, 2025

Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.

Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.

Journal: The Journal of dermatological treatment

Published: October 10, 2025

Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.

Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.

Journal: Italian journal of dermatology and venereology

Published: October 03, 2025

Role of the interleukin-15 pathway in vitiligo: Mechanistic insights and therapeutic implications.

Role of the interleukin-15 pathway in vitiligo: Mechanistic insights and therapeutic implications.

Journal: The Journal of investigative dermatology

Published: July 27, 2025

Showing 1-12 of 152

Last Updated: 09/26/2026